Imperial and Apollo Developing Potential Treatment for Pulmonary Hypertension
May 07, 2025
May 07, 2025
LONDON, England, May 7 -- Imperial College-London issued the following news:
* * *
Imperial and Apollo developing potential treatment for pulmonary hypertension
By David Silverman
A partnership designed to rapidly turn scientific breakthroughs into medicines has yielded a potential treatment for pulmonary arterial hypertension.
Imperial College London is working with Apollo Therapeutics to develop a prospective monoclonal antibody . . .
* * *
Imperial and Apollo developing potential treatment for pulmonary hypertension
By David Silverman
A partnership designed to rapidly turn scientific breakthroughs into medicines has yielded a potential treatment for pulmonary arterial hypertension.
Imperial College London is working with Apollo Therapeutics to develop a prospective monoclonal antibody . . .